Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why you need allergen component tests to support your allergy diagnosis

Niti Chokshi, MD and Gary Falcetano, PA
Conditions
July 30, 2024
Share
Tweet
Share

Almost 1 in 3 U.S. adults and more than 1 in 4 U.S. children reported having a seasonal allergy, eczema, or food allergy in 2021. That’s more than 100 million people and rates are rising. While many people experience relatively mild symptoms, for others, living with an allergy can be debilitating, with symptoms being severe and, in the worst cases, even fatal.

Therefore, it is essential to ensure patients have the most appropriate treatment plans and management strategies. An accurate diagnosis is the first step in optimizing patient care, and with a chronic shortage of board-certified allergists, primary care providers (PCPs) serve as the first line of defense for patients suffering.

As pressure mounts on PCPs to bridge the gap between increasing patient demand and diminishing board-certified allergist availability, the advantages of introducing allergen component testing into clinical pathways are becoming more apparent.

The limitations of existing practice

Clinicians can order general allergy testing in the form of a whole allergen-specific IgE blood test. Using a patient’s blood sample, the test measures the level of specific IgE antibodies in response to whole allergens, such as peanuts or dog dander. This helps build an understanding of a patient’s sensitizations but, alone, doesn’t provide the most comprehensive picture.

For example, whole allergen-specific IgE testing does not allow PCPs to gain insights around potential disease severity risks, the role that cross-reactivity may play in sensitizations with homologous proteins in other allergen sources, or help predict the future development of allergic disease in children. As a result, when using whole allergen-specific IgE testing on its own, PCPs will typically need to refer more patients than is strictly necessary to board-certified allergists for further testing or oral food challenge (OFC). Given the shortage of allergists, this can result in patients who don’t need to be referred unnecessarily experiencing significant waiting times and additional travel burdens. At the same time, patients who do need specialist care are forced to wait longer due to prolonged waiting lists in part caused by unnecessary referrals.

Instead, if PCPs use allergen component testing alongside whole allergen-specific IgE testing, they will be able to manage more patients’ treatment pathways independently and make better-informed specialist referrals when needed. But what is allergen component testing?

Whole allergen-specific IgE testing tests all the proteins within the allergen, including relevant ones and those that are not. In contrast, allergen component testing tests specific proteins to which a person is sensitized. This can better target which allergens may truly cause an allergic reaction in patients. In the same way that PCPs utilize a lipid profile to understand a patient’s total cholesterol and target intervention more effectively, the same is true for allergen component testing and suspected allergies. In other words, by combining whole allergen-specific IgE testing and allergen component testing, PCPs can first determine whether there is an allergy or not and, if the former, help to identify more precisely the allergens responsible for the symptoms. This approach can revolutionize allergy diagnosis and management for PCPs, potentially improving patient care and health outcomes.

Understanding the benefits of allergen component testing

Incorporating component testing can support PCPs to predict the tolerance of different forms of food allergens that a patient is sensitized to. For example, general tests like whole allergen and skin prick tests may reveal sensitization to eggs and dairy, but allergen component testing can reveal if the cause may be limited to fresh forms of these foods only or if cooked forms, such as baked eggs and dairy, may be safe. With more in-depth data, PCPs can offer improved dietary advice. In turn, patients benefit from an enhanced understanding of their specific triggers and can enjoy a wider range of foods and a better quality of life.

Similarly, by analyzing specific allergen components, PCPs may be able to identify patients who are at higher risk of experiencing severe allergic reactions following exposure to peanuts and tree nuts early in their care pathway. This can help reduce the risk of severe reactions by informing appropriate treatment and avoidance strategies. It can also support more comprehensive referrals to specialists, where OFC testing may be an appropriate next step to rule out clinical allergy and provide a more accurate diagnosis.

Guiding pet selection is another benefit PCPs can pass on to patients. Different pets produce varying levels of allergenic proteins, and the specific allergen components can differ among species and genders. By identifying the specific pet allergen components that an individual is sensitized to, PCPs can guide patients in selecting pets that are less likely to trigger reactions. For instance, whereas whole allergen testing may confirm sensitization to the whole allergen, research tells us that up to 58 percent of dog-allergic patients only react to Can f 5 proteins, produced in the prostate of male dogs. This suggests many patients sensitized only to Can f 5 could tolerate exposure to female dogs.

Interestingly, there is also a correlation between the number of pet allergen components a person is sensitized to and the severity of the disease they are likely to express. By introducing allergen component testing, PCPs can better predict the development and severity of respiratory disease. This is particularly useful for pediatric patients, with research indicating that the more pet allergen components a child is sensitized to at age 4, the more likely they are to demonstrate a clinical respiratory disease, such as rhinitis, rhinoconjunctivitis or asthma, at age 16.

ADVERTISEMENT

Component testing, therefore, supports early intervention, improved management strategies, and better-informed specialist referrals. This last point warrants further exploration, as a more precise understanding of allergen components can help PCPs determine if it is in the patient’s best interests to be referred to a specialist. This targeted approach ensures the right patients receive the right care from the right clinician, leading to improved patient outcomes while limiting unnecessary referrals and promoting health care efficiencies.

Take allergy diagnosis into your own hands.

Shortages of board-certified allergists, coupled with increasing allergy prevalence, are mounting pressure on PCPs to bridge the gap and better support patients. While many PCPs have already taken the first step towards this by utilizing whole allergen testing, incorporating allergen component testing has added benefits.

Allergen component testing — when used in conjunction with whole allergen-specific IgE testing and alongside clinical history — can identify sensitization to a host of allergen components, supporting more accurate and timely diagnosis. Armed with enhanced knowledge, PCPs can better predict tolerance to different forms of foods, identify patients who may be at higher risk of allergic reactions, guide pet selection, and help predict disease. With a diagnosis at the heart of the clinical pathway, allergy patients can be effectively qualified for specialist referrals, treatment plans, and management strategies can be better targeted, and patient care can be improved to maximize the quality of life for allergy patients.

Niti Chokshi is an allergy-immunology physician and Gary Falcetano is a health care executive.

Prev

Are Ozempic patients on a slow-moving runaway train?

July 30, 2024 Kevin 1
…
Next

The sham peer review: a hidden contributor to the doctor shortage

July 30, 2024 Kevin 2
…

Tagged as: Allergies & Immunology

Post navigation

< Previous Post
Are Ozempic patients on a slow-moving runaway train?
Next Post >
The sham peer review: a hidden contributor to the doctor shortage

ADVERTISEMENT

Related Posts

  • Intralymphatic immunotherapy: a breakthrough approach for allergies

    Amber Patterson, MD & Kara Wada, MD & Tiffany Owens, MD
  • When celebrities attack children with food allergies

    Lianne Mandelbaum, PT
  • How I used social media to get promoted to professor

    David R. Stukus, MD
  • Diagnosis: malformation of a health care system

    Jeffrey Fraser, MD
  • Getting a terminal diagnosis for my baby

    Sophia Zilber
  • Retrospective refusal of payment based upon final diagnosis compromises patients’ welfare

    David Hoke, MD, MBE, Kenneth V. Iserson, MD, MBA, and Jesse Basford, MD

More in Conditions

  • Could antibiotics beat heart disease where statins failed?

    Larry Kaskel, MD
  • Universities must tap endowments to sustain biomedical research

    Adeel Khan, MD
  • Apprenticeship reshapes medical training for confident clinicians

    Claude E. Lett III, PA-C
  • Why palliative care is more than just end-of-life support

    Dr. Vishal Parackal
  • My improbable survival of stage 4 cancer

    Kelly Curtin-Hallinan, DO
  • The truth about sun exposure: What dermatologists want you to know

    Shafat Hassan, MD, PhD, MPH
  • Most Popular

  • Past Week

    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • The dying man who gave me flowers changed how I see care

      Augusta Uwah, MD | Physician
    • Universities must tap endowments to sustain biomedical research

      Adeel Khan, MD | Conditions
    • Exploring the science behind burnout [PODCAST]

      The Podcast by KevinMD | Podcast
    • Apprenticeship reshapes medical training for confident clinicians

      Claude E. Lett III, PA-C | Conditions
    • How American medicine profits from despair

      Jenny Shields, PhD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • The dying man who gave me flowers changed how I see care

      Augusta Uwah, MD | Physician
    • Universities must tap endowments to sustain biomedical research

      Adeel Khan, MD | Conditions
    • Exploring the science behind burnout [PODCAST]

      The Podcast by KevinMD | Podcast
    • Apprenticeship reshapes medical training for confident clinicians

      Claude E. Lett III, PA-C | Conditions
    • How American medicine profits from despair

      Jenny Shields, PhD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...